Virtual Ward Rounds in Heart Failure: Personalising Management Across the EF Spectrum
Published: 18 January 2022
-
Views:
57176 -
Likes:
7
-
Views:
57176 -
Likes:
7
-
Up Next
-
9m 21sPart 2 | Session 2 Patient Profile 2: Follow up
-
9m 6sPart 2 | Session 3 Management De-brief of a Complex Case - Barriers in the Management of HFrEF
-
6m 54sPart 3 | Session 1 Patient Profile 1: Presented by Dr Kieran Docherty
-
8m 22sPart 3 | Session 2 Patient Profile 2: Presented by Dr Bharathi Upadhya
-
21m 24sPart 1 | Session 1 Ejection Fraction - How Important Is It Today? Martin R Cowie, Richard Hobbs, Bharathi Upadhya , Kieran Docherty
-
19m 49sPart 1 | Session 2 HFrEF and HFpEF Case Review Martin R Cowie, Richard Hobbs, Bharathi Upadhya , Kieran Docherty
-
15m 54sPart 1 | Session 3 The Expanding Role of Primary Care in Ongoing HF Management Martin R Cowie, Richard Hobbs, Bharathi Upadhya , Kieran Docherty
Overview
Watch this programme seeking to educate physicians in the changing landscape of the medical management of heart failure.
In the main event, Prof Martin Cowie (Royal Brompton Hospital, UK) chairs a roundtable discussion, and is joined by Dr Kieran Docherty (University of Glasgow, UK), Dr Bharathi Upadhya (Atrium Health Wake Forest Baptist, US) and Prof Richard Hobbs (University of Oxford, UK). During this roundtable, our expert panel discuss two patient cases and their treatment strategies based on recent guidelines and data updates. The panel also analyse survey data, discuss the importance of EF, and the role of primary care in ongoing heart failure management.
The final part explores how each of the patients has responded and how their quality of life and functional capacity has changed as a result. Dr Docherty also discusses the main challenges that he experienced during the management of his patient, and shares his advice on how complex patients like these can be treated.
Key Learning Objectives
Upon participation in this programme physicians should be able to:
- Apply results from real world and randomised controlled clinical trial data to surrogate, virtual patients
- Identify different HF phenotypes based on EF, patient age, sex and comorbidities
- Stratify stabilised HFpEF patients to an appropriate management approach according to patient characteristics
- Discuss the merits of using EF and other patient characteristics to guide treatment
Target Audience
- General Cardiologists
- Heart Failure Specialists
- Primary Care Physicians
- Allied Healthcare Professionals
- Nephrologists
More from this programme
Part 1
Roundtable Discussion
Part 2
Patient Follow Up
Part 3
Patient Case Presentations
Faculty Biographies
Kieran Docherty
Clinical Lecturer (Institute of Cardiovascular & Medical Sciences)
Kieran Docherty studied medicine at the University of Glasgow from 2005-2011. He is a Cardiology Specialist Registrar in the West of Scotland Deanery and a Clinical Research Fellow at the Institute of Cardiovascular and Medical Sciences at the University of Glasgow. He is undertaking a PhD examining the effects of neprilysin inhibition on left ventricular remodelling.